Free Trial
→ Trump wipes out trillions overnight… (From Porter & Company) (Ad) Buy VEON Stock  Free VEON Stock Alerts

VEON (VEON) Financials

VEON logo
$45.71 +0.05 (+0.11%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$45.71 0.00 (0.00%)
As of 05/2/2025 07:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for VEON

Annual Income Statements for VEON

This table shows VEON's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -655 -4,491 -10,042 582 771 -349 674 -162 -2,528 415
Consolidated Net Income / (Loss)		 -553 -4,583 -10,013 362 683 -316 801 -9.00 -2,450 487
Net Income / (Loss) Continuing Operations		 -815 -6,371 -10,013 -617 582 94 120 733 380 487
Total Pre-Tax Income 		-595 -5,736 -9,541 -248 1,132 373 464 802 559 704
Total Operating Income		 524 -5,701 -9,308 554 1,865 823 1,023 1,163 929 1,110
Total Gross Profit		 7,438 -86 -3,484 6,970 5,444 3,028 3,366 3,279 3,257 3,489
Total Revenue		 9,606 2,545 -410 9,086 8,162 3,482 3,850 3,755 3,698 4,004
Operating Revenue		 9,503 2,397 -410 9,086 7,987 3,482 3,725 3,628 3,595 3,871
Other Revenue		 103 148 - - 175 - 125 127 103 133
Total Cost of Revenue		 2,168 2,631 3,074 2,116 2,718 454 484 476 441 515
Operating Cost of Revenue		 2,168 2,631 3,074 2,116 2,718 454 484 476 441 515
Total Operating Expenses		 6,914 5,615 5,824 6,416 4,312 2,205 2,343 2,204 2,328 2,524
Selling, General & Admin Expense		 4,563 3,668 3,748 3,697 2,736 1,403 1,526 1,533 1,646 1,799
Depreciation Expense		 1,550 1,439 1,491 1,339 1,512 553 605 557 527 529
Amortization Expense		 517 497 537 495 - 177 194 221 208 199
Other Operating Expenses / (Income)		 39 11 22 -30 - 0.00 -9.00 0.00 -47 -6.00
Impairment Charge		 245 - - 858 108 62 27 -107 -6.00 3.00
Total Other Income / (Expense), net		 -1,119 -35 -233 -802 0.00 -450 -559 -273 -370 -415
Interest Expense		 829 - - 816 333 569 591 583 531 495
Interest & Investment Income		 52 - - 67 1.00 19 13 32 60 49
Other Income / (Expense), net		 -342 -35 -233 -53 332 100 19 278 101 31
Income Tax Expense		 220 635 472 369 462 279 344 69 179 217
Net Income / (Loss) Discontinued Operations		 262 1,788 - 979 101 -410 681 -742 -2,830 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest		 102 -92 29 -220 - 33 -127 -153 -78 -72
Basic Earnings per Share		 ($0.37) $1.33 - $0.33 - ($0.20) $0.38 $0.28 ($1.44) $0.23
Weighted Average Basic Shares Outstanding		 - - 1.76B 1.76B 1.76B 1.76B 1.76B 1.76B 1.76B 1.85B
Diluted Earnings per Share		 ($0.37) $1.33 - $0.33 - ($0.20) $0.38 ($0.09) ($1.44) $0.23
Weighted Average Diluted Shares Outstanding		 - - 1.76B 1.76B 1.76B 1.76B 1.76B 1.76B 1.76B 1.85B
Weighted Average Basic & Diluted Shares Outstanding		 - - 1.76B 1.76B 1.76B 1.76B 1.76B 1.76B 1.76B 1.85B

Quarterly Income Statements for VEON

No quarterly income statements for VEON are available.

Annual Cash Flow Statements for VEON

This table details how cash moves in and out of VEON's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -2,040 -922 -1,274 596 967 474 714 1,017 -1,271 -179
Net Cash From Operating Activities		 2,033 1,875 2,475 2,515 2,830 2,443 2,638 2,557 2,131 1,150
Net Cash From Continuing Operating Activities		 1,104 1,082 2,462 2,515 2,830 844 961 933 1,160 1,150
Net Income / (Loss) Continuing Operations		 -595 288 328 -248 0.00 373 464 802 559 704
Consolidated Net Income / (Loss)		 -595 288 328 -248 - 373 464 802 559 704
Depreciation Expense		 1,550 2,128 2,094 2,692 - 792 826 671 729 731
Non-Cash Adjustments To Reconcile Net Income		 -525 706 -227 -236 2,659 -321 550 274 469 -324
Changes in Operating Assets and Liabilities, net		 157 -2,040 267 307 171 0.00 -879 -814 -577 40
Net Cash From Discontinued Operating Activities		 929 683 - - - 1,599 1,677 1,624 951 0.00
Net Cash From Investing Activities		 -2,634 -2,671 -3,016 1,997 -1,582 -1,797 -1,122 -1,642 -2,036 -679
Net Cash From Continuing Investing Activities		 -2,494 -1,738 -3,036 1,997 -1,582 -816 -909 -1,043 -1,020 -778
Purchase of Property, Plant & Equipment		 -2,207 -1,651 -2,037 -1,948 -1,582 -550 -699 -634 -766 -627
Acquisitions		 -17 - - - - 0.00 0.00 -16 0.00 -2.00
Purchase of Investments		 - -87 -1,165 -32 - -132 -207 -390 - -280
Sale of Property, Plant & Equipment		 18 - - - - - - - - 102
Divestitures		 - 0.00 - - - -10 - - 0.00 36
Sale and/or Maturity of Investments		 74 - 166 3,958 - -8.00 - - - 92
Other Investing Activities, net		 -362 - - 19 - -47 -3.00 -3.00 -53 0.00
Net Cash From Discontinued Investing Activities		 -140 -649 - - - -1,050 -213 -599 -1,217 0.00
Net Cash From Financing Activities		 -1,439 -126 -733 -3,916 -281 -103 -744 116 -1,339 -543
Net Cash From Continuing Financing Activities		 -734 -106 -733 -3,916 -281 174 -192 456 -919 -551
Repayment of Debt		 -4,840 -1,816 -5,948 -4,122 -2,891 -4,148 -1,977 -1,619 -1,098 -1,483
Payment of Dividends		 -249 -167 -719 -601 - -298 -17 -12 -15 -15
Issuance of Debt		 2,052 1,882 6,193 807 2,610 4,621 2,081 2,087 - 955
Net Cash From Discontinued Financing Activities		 -707 -20 - - - -277 -552 -340 -226 0.00

Quarterly Cash Flow Statements for VEON

No quarterly cash flow statements for VEON are available.

Annual Balance Sheets for VEON

This table presents VEON's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 21,193 19,484 14,102 16,059 14,551 15,921 15,083 8,218 8,036
Total Current Assets		 4,550 3,164 3,110 2,499 2,850 3,553 3,981 3,158 2,828
Cash & Equivalents		 2,942 1,314 1,808 1,250 1,669 2,252 3,107 1,902 1,689
Short-Term Investments		 190 1,130 88 82 90 86 120 433 357
Accounts Receivable		 685 - 577 628 572 690 456 542 463
Inventories, net		 125 72 141 169 111 111 18 23 15
Current Deferred & Refundable Income Taxes		 169 - 112 16 73 70 72 58 63
Other Current Assets		 439 648 367 354 335 344 208 200 241
Plant, Property, & Equipment, net		 6,719 6,237 4,932 7,340 6,879 6,717 0.00 0.00 0.00
Total Noncurrent Assets		 9,899 5,239 6,077 6,220 670 5,651 8,254 2,162 2,192
Intangible Assets		 2,257 - 5,670 5,688 - 3,244 1,960 1,619 1,510
Noncurrent Deferred & Refundable Income Taxes		 343 336 197 134 186 228 274 312 368
Other Noncurrent Operating Assets		 424 263 193 398 484 315 228 231 242
Other Noncurrent Nonoperating Assets		 0.00 22 17 - 0.00 1,864 5,792 0.00 72
Total Liabilities & Shareholders' Equity		 21,193 19,484 14,102 16,059 14,551 15,921 15,083 8,218 8,036
Total Liabilities		 15,150 15,579 11,323 13,839 13,538 14,416 14,316 7,147 6,751
Total Current Liabilities		 6,557 4,635 4,413 5,768 4,410 4,383 4,645 3,584 3,626
Short-Term Debt		 3,046 1,268 1,289 2,585 1,255 1,242 2,844 1,692 1,666
Accounts Payable		 1,744 1,544 1,624 1,847 1,946 2,031 1,087 1,200 1,276
Current Deferred & Payable Income Tax Liabilities		 57 - 196 102 175 228 180 154 179
Other Current Liabilities		 1,236 1,401 1,066 1,012 883 773 475 457 432
Other Current Nonoperating Liabilities		 474 422 234 222 151 109 59 81 73
Total Noncurrent Liabilities		 8,593 10,944 6,910 8,071 9,128 9,642 5,439 3,563 3,125
Noncurrent Deferred & Payable Income Tax Liabilities		 331 376 180 141 127 115 36 26 27
Other Noncurrent Operating Liabilities		 8,262 10,568 6,730 7,930 9,001 9,527 5,403 3,537 3,098
Other Noncurrent Nonoperating Liabilities		 0.00 15 4.00 - 0.00 391 4,232 0.00 28
Total Equity & Noncontrolling Interests		 6,043 3,890 2,779 2,220 1,013 1,505 767 1,071 1,257
Total Preferred & Common Equity		 5,960 4,331 3,670 1,226 163 586 569 858 1,099
Total Common Equity		 5,960 4,331 3,670 1,226 163 586 569 858 1,099
Other Equity Adjustments		 5,960 4,331 3,670 1,226 163 586 569 858 1,099
Noncontrolling Interest		 83 -441 -891 994 850 919 198 213 158

Quarterly Balance Sheets for VEON

No quarterly balance sheets for VEON are available.

Annual Metrics and Ratios for VEON

This table displays calculated financial ratios and metrics derived from VEON's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 0.00% -73.51% -116.11% 2,316.10% -10.17% -57.34% 10.57% -2.47% -1.52% 8.27%
EBITDA Growth		 0.00% -260.43% -106.40% 142.88% 16.16% -53.76% 8.92% 13.06% -16.71% 11.56%
EBIT Growth		 0.00% -3,251.65% -66.34% 105.25% 338.52% -57.99% 12.89% 38.29% -28.52% 20.23%
NOPAT Growth		 0.00% -1,187.98% -63.27% 105.95% 184.64% -81.21% 27.56% 301.76% -40.59% 21.59%
Net Income Growth		 0.00% -728.75% -118.48% 103.62% 88.67% -146.27% 353.48% -101.12% -27,122.22% 119.88%
EPS Growth		 0.00% 459.46% 0.00% 0.00% 0.00% 0.00% 353.48% -101.12% -1,500.00% 115.97%
Operating Cash Flow Growth		 0.00% -7.77% 32.00% 1.62% 12.52% -13.67% 7.98% -3.07% -16.66% -46.03%
Free Cash Flow Firm Growth		 0.00% 0.00% 93.02% -548.57% 94.67% 3,831.58% -130.73% 279.23% -123.19% 151.76%
Invested Capital Growth		 0.00% 0.00% -140.57% 239.53% 54.41% -194.51% 72.65% -315.18% 39.75% 11.68%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 77.43% -3.38% 0.00% 76.71% 66.70% 86.96% 87.43% 87.32% 88.07% 87.14%
EBITDA Margin		 23.41% -141.77% 0.00% 35.14% 45.44% 49.25% 48.52% 56.25% 47.57% 46.75%
Operating Margin		 5.45% -224.01% 0.00% 6.10% 22.85% 23.64% 26.57% 30.97% 25.12% 27.72%
EBIT Margin		 1.89% -225.38% 0.00% 5.51% 26.92% 26.51% 27.06% 38.38% 27.85% 28.50%
Profit (Net Income) Margin		 -5.76% -180.08% 0.00% 3.98% 8.37% -9.08% 20.81% -0.24% -66.25% 12.16%
Tax Burden Percent		 92.94% 79.90% 104.95% -145.97% 60.34% -84.72% 172.63% -1.12% -438.28% 69.18%
Interest Burden Percent		 -326.92% 100.00% 100.00% -49.50% 51.52% 40.41% 44.53% 55.66% 54.27% 61.70%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 40.81% 74.80% 74.14% 8.60% 32.02% 30.82%
Return on Invested Capital (ROIC)		 0.00% -188.82% 0.00% 114.40% 36.26% 204.34% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -123.59% 0.00% 115.26% -41.03% 238.89% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 37.14% 0.00% -103.54% -8.94% -223.89% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 0.00% -151.68% -201.61% 10.86% 27.33% -19.55% 63.62% -0.79% -266.59% 41.84%
Cash Return on Invested Capital (CROIC)		 0.00% -388.82% 0.00% -155.46% -6.51% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% -27.07% 0.00% 2.98% 14.57% 6.03% 6.84% 9.30% 8.84% 14.04%
Return on Assets (ROA)		 0.00% -21.63% 0.00% 2.16% 4.53% -2.06% 5.26% -0.06% -21.03% 5.99%
Return on Common Equity (ROCE)		 0.00% -149.60% -208.88% 13.02% 26.76% -8.40% 18.92% -0.40% -206.98% 35.17%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -76.90% -231.19% 9.86% 55.71% -193.87% 136.69% -1.58% -285.55% 44.31%
Net Operating Profit after Tax (NOPAT)		 367 -3,991 -6,516 388 1,104 207 265 1,063 632 768
NOPAT Margin		 3.82% -156.81% 0.00% 4.27% 13.52% 5.96% 6.87% 28.31% 17.08% 19.18%
Net Nonoperating Expense Percent (NNEP)		 0.00% -65.23% -94.26% -0.86% 77.29% -34.55% 15.40% -29.81% -75.23% -8.23%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - - 26.27%
Cost of Revenue to Revenue		 22.57% 103.38% 0.00% 23.29% 33.30% 13.04% 12.57% 12.68% 11.93% 12.86%
SG&A Expenses to Revenue		 47.50% 144.13% 0.00% 40.69% 33.52% 40.29% 39.64% 40.83% 44.51% 44.93%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 71.98% 220.63% 0.00% 70.61% 52.83% 63.33% 60.86% 58.70% 62.95% 63.04%
Earnings before Interest and Taxes (EBIT)		 182 -5,736 -9,541 501 2,197 923 1,042 1,441 1,030 1,141
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 2,249 -3,608 -7,447 3,193 3,709 1,715 1,868 2,112 1,759 1,872
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.93 3.38 16.27 5.13 1.51 40.34 64.10
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 16.27 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.38 0.51 0.76 0.78 0.23 9.36 17.59
Price to Earnings (P/E)		 0.00 0.00 0.00 5.85 5.38 0.00 4.46 0.00 0.00 169.75
Dividend Yield		 1.55% 1.31% 11.83% 14.95% 12.71% 29.80% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 17.08% 18.59% 0.00% 22.44% 0.00% 0.00% 0.59%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.80 1.73 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.21 0.78 0.86 0.73 0.18 9.24 17.54
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.60 1.72 1.75 1.51 0.32 19.43 37.51
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 3.81 2.91 3.25 2.71 0.47 33.18 61.55
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 4.92 5.79 14.46 10.69 0.64 54.12 91.45
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.76 2.26 1.23 1.07 0.26 16.04 61.06
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.41 0.00 0.17 0.00 143.65
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.00 0.50 0.33 0.46 1.16 1.24 0.83 3.71 1.58 1.33
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 0.00 -0.30 -0.75 -0.90 0.22 -0.94 -2.77 -3.17 -4.46 -2.93
Leverage Ratio		 0.00 3.51 4.10 5.04 6.03 9.47 12.10 13.65 12.68 6.98
Compound Leverage Factor		 0.00 3.51 4.10 -2.49 3.11 3.83 5.39 7.59 6.88 4.31
Debt to Total Capital		 0.00% 33.51% 24.58% 31.69% 53.80% 55.34% 45.21% 78.76% 61.24% 57.00%
Short-Term Debt to Total Capital		 0.00% 33.51% 24.58% 31.69% 53.80% 55.34% 45.21% 78.76% 61.24% 57.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.91% -8.55% -21.90% 20.69% 37.48% 33.45% 5.48% 7.71% 5.41%
Common Equity to Total Capital		 0.00% 65.57% 83.97% 90.22% 25.52% 7.19% 21.33% 15.76% 31.05% 37.60%
Debt to EBITDA		 0.00 -0.84 -0.17 0.40 0.70 0.73 0.66 1.35 0.96 0.89
Net Debt to EBITDA		 0.00 0.63 0.16 -0.19 0.34 -0.29 -0.59 -0.18 -0.37 -0.20
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 -0.76 -0.19 3.32 2.34 6.05 4.69 2.68 2.68 2.17
Net Debt to NOPAT		 0.00 0.57 0.18 -1.57 1.14 -2.43 -4.14 -0.36 -1.02 -0.49
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 0.00 0.00 0.00 0.83 0.90 0.44 0.52 0.55 3.71 7.11
Noncontrolling Interest Sharing Ratio		 0.00% 1.37% -3.60% -19.97% 2.06% 57.04% 70.25% 49.16% 22.36% 15.94%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 0.00 0.69 0.68 0.70 0.43 0.65 0.81 0.86 0.88 0.78
Quick Ratio		 0.00 0.58 0.53 0.56 0.34 0.53 0.69 0.79 0.80 0.69
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -8,218 -574 -3,720 -198 7,394 -2,272 4,073 -944 489
Operating Cash Flow to CapEx		 92.87% 113.57% 121.50% 129.11% 178.89% 444.18% 377.40% 403.31% 278.20% 219.05%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 -4.56 -0.60 13.00 -3.85 6.99 -1.78 0.99
Operating Cash Flow to Interest Expense		 2.45 0.00 0.00 3.08 8.50 4.29 4.46 4.39 4.01 2.32
Operating Cash Flow Less CapEx to Interest Expense		 -0.19 0.00 0.00 0.69 3.75 3.33 3.28 3.30 2.57 1.26
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.00 0.12 0.00 0.54 0.54 0.23 0.25 0.24 0.32 0.49
Accounts Receivable Turnover		 0.00 3.72 0.00 0.00 13.55 5.80 6.10 6.55 7.41 7.97
Inventory Turnover		 0.00 21.05 31.21 19.87 17.54 3.24 4.36 7.38 21.51 27.11
Fixed Asset Turnover		 0.00 0.38 0.00 1.63 1.33 0.49 0.57 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 1.51 1.87 1.34 1.57 0.24 0.24 0.31 0.39 0.42
Days Sales Outstanding (DSO)		 0.00 98.24 0.00 0.00 26.94 62.89 59.82 55.70 49.25 45.81
Days Inventory Outstanding (DIO)		 0.00 17.34 11.70 18.37 20.81 112.56 83.71 49.46 16.97 13.47
Days Payable Outstanding (DPO)		 0.00 241.95 195.20 273.23 233.06 1,524.72 1,499.59 1,195.45 946.43 877.42
Cash Conversion Cycle (CCC)		 0.00 -126.36 0.00 -254.86 -185.30 -1,349.27 -1,356.06 -1,090.29 -880.21 -818.14
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 0.00 4,227 -1,715 2,393 3,695 -3,492 -955 -3,965 -2,389 -2,110
Invested Capital Turnover		 0.00 1.20 0.00 26.80 2.68 34.31 -1.73 -1.53 -1.16 -1.78
Increase / (Decrease) in Invested Capital		 0.00 4,227 -5,942 4,108 1,302 -7,187 2,537 -3,010 1,576 279
Enterprise Value (EV)		 0.00 0.00 0.00 1,910 6,394 2,999 2,827 676 34,178 70,223
Market Capitalization		 0.00 0.00 0.00 3,408 4,147 2,653 3,004 861 34,608 70,445
Book Value per Share		 $0.00 $0.00 $2.47 $2.09 $0.70 $0.09 $0.33 $0.32 $0.49 $0.63
Tangible Book Value per Share		 $0.00 $0.00 ($0.16) ($1.14) ($2.54) $0.09 ($1.51) ($0.79) ($0.43) ($0.23)
Total Capital		 0.00 9,089 5,158 4,068 4,805 2,268 2,747 3,611 2,763 2,923
Total Debt		 0.00 3,046 1,268 1,289 2,585 1,255 1,242 2,844 1,692 1,666
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 0.00 -2,265 -1,176 -607 1,253 -504 -1,096 -383 -643 -380
Capital Expenditures (CapEx)		 2,189 1,651 2,037 1,948 1,582 550 699 634 766 525
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 -2,093 -2,647 -1,910 -2,016 -2,064 -1,926 -1,047 -1,069 -1,178
Debt-free Net Working Capital (DFNWC)		 0.00 1,039 -203 -14 -684 -305 412 2,180 1,266 868
Net Working Capital (NWC)		 0.00 -2,007 -1,471 -1,303 -3,269 -1,560 -830 -664 -426 -798
Net Nonoperating Expense (NNE)		 920 592 3,497 26 421 523 -536 1,072 3,082 281
Net Nonoperating Obligations (NNO)		 0.00 -1,816 -5,605 -386 1,475 -4,505 -2,460 -4,732 -3,460 -3,367
Total Depreciation and Amortization (D&A)		 2,067 2,128 2,094 2,692 1,512 792 826 671 729 731
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% -82.24% 0.00% -21.02% -24.70% -59.28% -50.03% -27.88% -28.91% -29.42%
Debt-free Net Working Capital to Revenue		 0.00% 40.83% 0.00% -0.15% -8.38% -8.76% 10.70% 58.06% 34.23% 21.68%
Net Working Capital to Revenue		 0.00% -78.86% 0.00% -14.34% -40.05% -44.80% -21.56% -17.68% -11.52% -19.93%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($7.00) $0.00 $9.00 ($5.00) $0.00 ($0.09) ($1.44) $0.23
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 70.27M 70.27M 70.27M 70.27M 0.00 1.76B 1.76B 1.85B
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($7.00) $0.00 $9.00 ($5.00) $0.00 ($0.09) ($1.44) $0.23
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 70.27M 70.27M 70.27M 70.27M 0.00 1.76B 1.76B 1.85B
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 ($7.00) $0.00 $9.00 ($5.00) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 70.27M 70.27M 70.27M 70.27M 0.00 1.76B 1.76B 1.85B
Normalized Net Operating Profit after Tax (NOPAT)		 538 -3,991 -6,497 1,028 1,142 627 735 965 627 770
Normalized NOPAT Margin		 5.60% -156.81% 0.00% 11.32% 13.99% 17.99% 19.09% 25.70% 16.97% 19.23%
Pre Tax Income Margin		 -6.19% -225.38% 0.00% -2.73% 13.87% 10.71% 12.05% 21.36% 15.12% 17.58%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.22 0.00 0.00 0.61 6.60 1.62 1.76 2.47 1.94 2.31
NOPAT to Interest Expense		 0.44 0.00 0.00 0.48 3.31 0.36 0.45 1.82 1.19 1.55
EBIT Less CapEx to Interest Expense		 -2.42 0.00 0.00 -1.77 1.85 0.66 0.58 1.38 0.50 1.24
NOPAT Less CapEx to Interest Expense		 -2.20 0.00 0.00 -1.91 -1.44 -0.60 -0.74 0.74 -0.25 0.49
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 -45.03% -3.64% -7.18% 166.02% 0.00% -94.30% 2.12% -133.33% -0.61% 3.08%
Augmented Payout Ratio		 -45.03% -3.64% -7.18% 166.02% 0.00% -94.30% 2.12% -133.33% -0.61% 3.08%

Quarterly Metrics and Ratios for VEON

No quarterly metrics and ratios for VEON are available.

Frequently Asked Questions About VEON's Financials

When does VEON's fiscal year end?

According to the most recent income statement we have on file, VEON's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has VEON's net income changed over the last 9 years?

VEON's net income appears to be on a downward trend, with a most recent value of $487 million in 2024, falling from -$553 million in 2015. The previous period was -$2.45 billion in 2023. See VEON's forecast for analyst expectations on what’s next for the company.

What is VEON's operating income?
VEON's total operating income in 2024 was $1.11 billion, based on the following breakdown:
  • Total Gross Profit: $3.49 billion
  • Total Operating Expenses: $2.52 billion
How has VEON revenue changed over the last 9 years?

Over the last 9 years, VEON's total revenue changed from $9.61 billion in 2015 to $4.00 billion in 2024, a change of -58.3%.

How much debt does VEON have?

VEON's total liabilities were at $6.75 billion at the end of 2024, a 5.5% decrease from 2023, and a 55.4% decrease since 2016.

How much cash does VEON have?

In the past 8 years, VEON's cash and equivalents has ranged from $1.25 billion in 2019 to $3.11 billion in 2022, and is currently $1.69 billion as of their latest financial filing in 2024.

How has VEON's book value per share changed over the last 9 years?

Over the last 9 years, VEON's book value per share changed from 0.00 in 2015 to 0.63 in 2024, a change of 62.6%.


Related Companies

This page (NASDAQ:VEON) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners
Think NVDA’s run was epic? You ain’t seen nothin’ yet
Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...
Timothy Sykes | Sponsored
Elon’s Terrifying Warning Forces Trump To Take Action
Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...
American Hartford Gold | Sponsored
Elon Set to Shock the World by May 1st ?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...
Brownstone Research | Sponsored
Gold Alert: The Truth About Fort Knox Is Coming
Owning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...
Golden Portfolio | Sponsored
How to invest in Elon Musk’s Optimus before its launch
Elon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...
InvestorPlace | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Trump to solve American wealth loss?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored
Trump’s Bitcoin Reserve is No Accident…
Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...
Crypto 101 Media | Sponsored